CAPRICOR THERAPEUTICS, INC. Other Long-term Debt
CAPRICOR THERAPEUTICS, INC. (CAPR) had Other Long-term Debt of $3.38 million as of 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:OtherLongTermDebt · last filed 2022-03-11
- 2021-12-31: Other Long-term Debt $3.38M.
- 2021-09-30: Other Long-term Debt $3.38M.
- 2021-06-30: Other Long-term Debt $3.38M.
- 2021-03-31: Other Long-term Debt $3.38M.
| Period end | Other Long-term Debt |
|---|---|
| 2021-12-31 | $3.38M 10-K · filed 2022-03-11 |
| 2021-09-30 | $3.38M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $3.38M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $3.38M 10-Q · filed 2021-05-14 |
| 2020-12-31 | $3.38M 10-K · filed 2022-03-11 |
| 2020-09-30 | $3.38M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $3.38M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $3.38M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $3.38M 10-K · filed 2021-03-15 |
| 2019-09-30 | $3.38M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $3.38M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $3.38M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $3.38M 10-K · filed 2020-03-27 |
| 2018-09-30 | $3.38M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $3.38M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $3.38M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $3.38M 10-K · filed 2019-03-29 |
| 2017-09-30 | $3.38M 10-Q · filed 2017-11-14 |
| 2017-06-30 | $3.10M 10-Q · filed 2017-08-14 |
| 2017-03-31 | $3.10M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $3.10M 10-K · filed 2018-03-22 |
| 2016-09-30 | $3.10M 10-Q · filed 2016-11-14 |
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |